Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Erik Greb

  • News

    Intensive blood pressure lowering may not reduce risk of recurrent stroke

    March 20, 2019

    HONOLULU – Intensive treatment significantly reduces blood pressure, compared with standard treatment, and is equally safe.

  • 1
    News

    Andexanet alfa effectively reverses factor Xa inhibition

    March 18, 2019

    HONOLULU – The drug establishes good or excellent hemostasis in 82% of patients with acute major bleeding associated with factor Xa inhibition.

  • News

    Glyceryl trinitrate does not improve outcomes of ischemic stroke

    March 7, 2019

    HONOLULU – Although treatment reduced blood pressure, it did not reduce disability at 90 days, compared with sham.

  • 1
    News

    Deferoxamine does not improve 90-day outcomes after ICH

    February 14, 2019

    HONOLULU – The drug is safe, and data suggest that it could improve 180-day outcomes.

  • 1
    News

    Cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke

    February 7, 2019

    HONOLULU – Dual therapy with cilostazol and aspirin or clopidogrel did not increase the risk of serious bleeding.

  • News

    Benefit of thrombectomy may be universal

    January 28, 2019

    The proportional benefit of thrombectomy is uniform among various subgroups of patients with acute ischemic stroke.

  • News

    AAN publishes position statement on brain death

    January 8, 2019

    The association calls for uniform laws and policies regarding brain death, as well as continued research and public education.

Previous1 2
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences